Skip to main content

Table 1 Clinicopathological parameters of 62 TH and TC patients

From: Functional apoptosis profiling identifies MCL-1 and BCL-xL as prognostic markers and therapeutic targets in advanced thymomas and thymic carcinomas

Patients

62

 Male (%)

28 (45)

 Female (%)

34 (55)

Age (range)

61 (28–88)

Type (%)

 

 A

7 (11.3)

 AB

19 (30.6)

 B1

2 (3.2)

 B2

16 (25.8)

 B3

9 (14.5)

 C

9 (14.5)

Masaoka-Koga stage (%)

 

 1

16 (25.8)

 2

20 (32.2)

 3

14 (22.6)

 4

8 (12.9)

 Unknown

4 (6.5)

Median follow-up time in months (range)

46 (1–240)

Reported death (%)

20 (32.3)